6:28 PM Apr 20, 2018

Redrawing the lines

Word that Merck & Co. Inc.’s Keytruda pembrolizumab had “won” the first-line lung cancer showdown with Bristol-Myers Squibb Co. at AACR spread quickly on Monday, but there was little...

4:45 PM Apr 20, 2018

Lessons from the ECHO chamber

Lessons from the failure of ECHO-301 go beyond the prospects of combining IDO1 and PD-1 inhibition to treat cancer. The broader concern is for the gamut of Phase I/II trials testing PD-1...

10:39 AM Apr 20, 2018

Refilling Alexion’s cupboard

The first deal by Alexion Pharmaceuticals Inc.’s freshly rebuilt management team serves to amplify its biggest challenge -- it needs many more external assets to break its Soliris eculizumab...

5:00 PM Apr 19, 2018

Structured outlook

A Cell study capturing hundreds of E. coli mRNA structures makes the case that complex, functionally relevant RNA structures are the rule, not the exception, and builds confidence that mRNAs --...

4:58 PM Apr 19, 2018

Automation navigation

Last year’s approvals of the first two CAR T therapies have prompted the field to get serious about industrializing manufacturing of the cells to improve reproducibility and lower costs. While...

1
2
3
4
5

Latest News

4:55 PM Apr 24, 2018

Shire to consider revised Takeda bid

Shire plc (LSE:SHP; NASDAQ:SHPG) said late Tuesday its board is willing to recommend to shareholders a...

3:47 PM Apr 24, 2018

Amgen considering risk-based Aimovig pricing

On a conference call to discuss 1Q18 earnings call, Amgen Inc. (NASDAQ:AMGN) EVP of Global Commercial...

3:24 PM Apr 24, 2018

Merck adds affinity optimization to nanoscale synthesis system

A Nature paper from Merck & Co. Inc. (NYSE:MRK) describes a nanoscale synthesis system that...

3:15 PM Apr 24, 2018

Diabetes franchise drives 1Q18 for Lilly

Strong sales from the diabetes franchise of Eli Lilly and Co. (NYSE:LLY) led to 1Q18 results that outpaced...

2:22 PM Apr 24, 2018

HKEX finalizes biotech chapter listing rules

Hong Kong Exchanges and Clearing Ltd. (HKEX) released final rules for the listing of pre-revenue biotech...

2:16 PM Apr 24, 2018

Biogen looks to ex-U.S. markets for growth

Biogen Inc. (NASDAQ:BIIB) perceives greater long-term growth opportunities than anticipated in the EU and...

1:13 PM Apr 24, 2018

Imfinzi combo misses in NSCLC subpopulation

AstraZeneca plc (LSE:AZN; NYSE:AZN) said Imfinzi durvalumab plus tremelimumab as third-line treatment...

1:07 PM Apr 24, 2018

Carter introduces 340B transparency bill

Congressman Earl Carter (R-Ga.) introduced legislation Tuesday to increase transparency into the 340B drug...

10:34 AM Apr 24, 2018

Epizyme falls on clinical hold

Epizyme Inc. (NASDAQ:EPZM) fell $2.30 (15%) to $13 in afternoon trading Tuesday after reporting late...

10:05 AM Apr 24, 2018

PureTech names Joep Muijrers CFO

PureTech Health plc (LSE:PRTC) hired Joep Muijrers as CFO. He was a partner and portfolio manager at Life...

8:23 AM Apr 24, 2018

Reed replacing Zerhouni at Sanofi

Head of Global R&D Elias Zerhouni will retire from Sanofi (Euronext:SAN; NYSE:SNY), effective June 30....

8:16 AM Apr 24, 2018

Supreme Court retains, complicates IPR

The Supreme Court Tuesday upheld the constitutionality of the inter partes review process for challenging...

6:59 AM Apr 24, 2018

Nextech leads Revolution Medicines' $56M series B

Revolution Medicines Inc. (Redwood City, Calif.) raised $56 million in a series B round led by new...

4:17 AM Apr 24, 2018

Protein stability play Cedilla launches with $56.2M series A

Third Rock Ventures launched Cedilla Therapeutics Inc. (Cambridge, Mass.) with a tranched $56.2 million...

4:24 PM Apr 23, 2018

FDA committee split on Olumiant dosing

FDA's Arthritis Advisory Committee voted Monday in favor of approving a once-daily 2 mg dose of rheumatoid...

4:07 PM Apr 23, 2018

Management tracks: Probiodrug, Alder

Neurology company Probiodrug AG (Euronext:PBD) said Chairman and CEO Konrad Glund will retire, effective...

4:05 PM Apr 23, 2018

Clarus, Sofinnova Partners announce new hires

Life sciences investment firm Clarus Ventures LLC (Cambridge, Mass.) hired Paris Panayiotopoulos as...

3:53 PM Apr 23, 2018

CAR T against cell surface proteins to treat prostate cancer

Researchers at University of California Los Angeles identified cell surface targets to treat prostate...

3:43 PM Apr 23, 2018

FDA places hold on Epizyme's tazemetostat

Epizyme Inc. (NASDAQ:EPZM) fell $2.90 (19%) to $12.40 in after-hours trading Monday after FDA placed a...

3:33 PM Apr 23, 2018

Ping An Healthcare sets IPO range

Ping An Healthcare and Technology Co. Ltd. (Shanghai, China) amended its IPO on the Hong Kong stock...

Down Up